JPRN-UMIN000008241已完成未知
Beneficial Effect of Sarpogrelate on Quality of Life in Patients with Peripheral Arterial Disease - Beneficial Effect of Sarpogrelate on Quality of Life in Patients with Peripheral Arterial Disease
Division of Vascular Surgery, University of Tokyo0 个研究点目标入组 50 人开始时间: 2012年6月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients with bleeding tendency 2. patients on maintenance hemodialysis 3. patients on cilostazol or beraprost sodium
研究者
相似试验
招募中
不适用
Effects of Sarpogrelate sustained release treatment on improvement of ischemic symptoms and hepatologic changes(whole blood viscosity changes) in patients with type 2 diabetic peripheral vascular disease, Single-center, randomized, open, Parallel, Phase 4 clinical trialEndocrine, nutritional and metabolic diseasesKCT0005088Seoul National University Bundang Hospital60
尚未招募
不适用
Effect of sarpogrelate on angiographic luminal loss and clinical outcome after endovascular treatment for peripheral artery diseaseDiseases of the circulatory systemKCT0004511Dong-A University Hospital50
招募中
2 期
Effect of magnesium sulfate on blood infectioSepsis.Gram-negative sepsis, unspecifiedA41.50IRCT20180410039254N1Tehran University of Medical Sciences50
已完成
4 期
The effect of the low-dose spironolactone in post adolescent acne: a randomized, double-blind, placebo-controlled trial.acne vulgaris in women who age from 25ᇁ years oldspironolactonepostadolescent acneTCTR20190417004Faculty of Medicine, Chulalongkorn University62
尚未招募
3 期
Effect of 25 and 100 mg spironolactone on quality of life, ejection fraction and readmission in systolic heart failure patients with reduced ejection fractioIRCT20220404054403N1Ahvaz University of Medical Sciences94